Al-Dawaa Medical Services Company (4163.SR) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Al-Dawaa Medical Services Company, with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | 13.17x | 18.01x | 27.32x | 20.62x | 27.94x | 27.11x |
| P/B Ratio | 2.92x | 4.58x | 6.85x | 5.75x | 6.75x | 6.00x |
| P/S Ratio | 0.63x | 1.03x | 1.57x | 1.17x | 1.33x | 1.35x |
| Profitability | ||||||
| Gross Margin | 35.2% | 35.5% | 36.0% | 37.6% | 37.6% | 31.7% |
| Operating Margin | 6.9% | 8.0% | 8.1% | 6.9% | 5.3% | 8.0% |
| Net Margin | 4.8% | 5.7% | 5.7% | 5.7% | 4.8% | 5.0% |
| EBITDA Margin | 13.1% | 13.9% | 14.5% | 14.6% | 13.2% | 12.6% |
| Liquidity | ||||||
| Current Ratio | 1.21x | 1.15x | 1.12x | 1.10x | 0.89x | 1.08x |
| Quick Ratio | 0.33x | 0.45x | 0.39x | 0.44x | 0.26x | 0.19x |
| Leverage | ||||||
| Debt/Equity | 1.58x | 1.44x | 1.75x | 2.40x | 2.22x | 1.49x |
YoY = year-over-year change. Source: FMP..